By Jonathan Weiss | Wed, 06/12/2013 - 10:36
With a high cost and only marginal benefits, the new weight loss drug may not be helpful to a majority of people.
By Nsikan Akpan | Tue, 06/04/2013 - 17:04
A new study estimates 'evergreen' policies that extend the life of drug patents substantially increased health care costs in Geneva.
By Jonathan Weiss | Wed, 05/29/2013 - 17:25
GSK's new melanoma drugs are targeted toward specific mutations present in the skin cancer.
By Jonathan Weiss | Sun, 05/26/2013 - 11:41
Liraglutide (Victoza), currently approved to treat type 2 diabetes, will be re-branded and sold as a weight-loss aid.
By Jonathan Weiss | Thu, 05/23/2013 - 11:09
Already approved for breast cancer treatment, ABRAXANE has shown promise in increasing survival of advanced pancreatic cancer patients.
By Jonathan Weiss | Mon, 05/20/2013 - 10:47
A promising sleeping pill, with fewer side effects than current drugs on the market, is in the midst of the FDA approval process.
By Jonathan Weiss | Fri, 05/17/2013 - 16:23
The new drug will soon be submitted to the FDA for approval to treat the blood cell proliferative disorder myelofibrosis.
By Jonathan Weiss | Mon, 05/13/2013 - 10:21
With stunning results in Phase III clinical trials, the hepatitis C drug is now on a fast track for FDA approval.
By Ashik Siddique | Mon, 04/22/2013 - 20:18
A computer algorithm has mapped all the possible carbon-based structures in the ‘small molecule universe’ that might be created as drugs in pharmaceutical labs— even chemical compounds that don’t exist yet.
By Jonathan Weiss | Tue, 02/05/2013 - 10:05
The FDA has taken drastic measures to increase availability of Doxil, a cancer drug that is in short supply.